The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study
Abstract
Purpose: To evaluate the prevalence of cardiovascular risk factors and long-term incidence of cardiovascular disease (CVD) in survivors of testicular cancer (TC). Methods: Overall, 990 men treated for unilateral TC (1980 to 1994) were included in this national follow-up study (2007 to 2008). They were categorized into four treatment groups: surgery (n = 206), radiotherapy only (RT; n = 386), chemotherapy only (n = 364), and combined RT/chemotherapy (n = 34). Age-matched male controls from the general population (ie, NORMs) were included (n = 990). Survivors of TC who were diagnosed with CVD before or within 2 years after the TC diagnosis were excluded from analyses of CVD end points. Results: Median observation time was 19 years (range, 13 to 28 years). All cytotoxic treatment groups had significantly increased prevalences of antihypertensive medication, and survivors in the RT and RT/chemotherapy groups had higher prevalences of diabetes (RT: odds ratio [OR], 2.3; 95% CI, 1.5 to 3.7; RT/chemotherapy: OR, 3.9; 95% CI, 1.4 to 10.9) compared with NORMs. Overall 74 survivors of TC (8.0%) experienced atherosclerotic disease during follow-up. Increased risks for atherosclerotic disease were observed in age-adjusted Cox regression analyses after any cytotoxic treatment when compared with surgery only (RT: hazard ratio [HR], 2.3; 95% CI, 1.04 to 5.3; chemotherapy: HR, 2.6; 95% CI, 1.1 to 5.9; RT/chemotherapy: HR, 4.8; 95% CI, 1.6 to 14.4). Treatment with cisplatin, bleomycin, and etoposide (BEP) alone had a 5.7-fold higher risk (95% CI, 1.9 to 17.1 fold) for coronary artery disease compared with surgery only and a 3.1-fold higher risk (95% CI, 1.2 to 7.7 fold) for myocardial infarction compared with NORMs. Conclusion: Treatment with infradiaphragmatic RT and/or cisplatin-based chemotherapy, particularly the BEP regimen, increases the long-term risk for CVD in survivors of TC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3527 · Cited by 2,256
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285
Williams, S. D., Birch, R., Einhorn, L. H., Irwin, L., Greco, F. A., & Loehrer, P. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162302 · Cited by 1,170
McKeown, R. E. (2002) · Epidemiology · doi:10.1097/00001648-200209000-00019 · Cited by 765
Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., et al. (2008) · European Urology · doi:10.1016/j.eururo.2007.12.024 · Cited by 617
Self-citationCardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer
Huddart, R. A., Norman, A., Shahidi, M., Horwich, A., Coward, D., Nicholls, J., & Dearnaley, D. P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.173 · Cited by 547
Cardiovascular Morbidity in Long-Term Survivors of Metastatic Testicular Cancer
Meinardi, M. T., Gietema, J. A., van der Graaf, W. T. A., van Veldhuisen, D. J., Runne, M. A., Sluiter, W. J., de Vries, E. G. E., Willemse, P. B. H., Mulder, N. H., van den Berg, M. P., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1725 · Cited by 489
Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer
van den Belt-Dusebout, A. W., Nuver, J., de Wit, R., Gietema, J. A., ten Bokkel Huinink, W. W., Rodrigus, P. T. R., Schimmel, E. C., Aleman, B. M. P., & van Leeuwen, F. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7193 · Cited by 345
Haring, R., Volzke, H., Steveling, A., Krebs, A., Felix, S. B., Schofl, C., Dorr, M., Nauck, M., & Wallaschofski, H. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq009 · Cited by 311
Mortality After Cure of Testicular Seminoma
Zagars, G. K., Ballo, M. T., Lee, A. K., & Strom, S. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.205 · Cited by 286
Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Ståhl, E., et al. (2008) · European Urology · doi:10.1016/j.eururo.2007.12.025 · Cited by 252
Self-citationCOMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTIS
Peckham, M. J., Barrett, A., Mcelwain, T. J., & Hendry, W. F. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90288-5 · Cited by 246
The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease
Traish, A. M., Saad, F., Feeley, R. J., & Guay, A. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.007245 · Cited by 239
Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer
Gietema, J., Meinardi, M., Messerschmidt, J., Gelevert, T., Alt, F., Uges, D., & Th Sleijfer, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02044-4 · Cited by 216
Components of the metabolic syndrome in long-term survivors of testicular cancer
Haugnes, H. S., Aass, N., Fosså, S. D., Dahl, O., Klepp, O., Wist, E. A., Svartberg, J., Wilsgaard, T., & Bremnes, R. M. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl372 · Cited by 183
Self-citationBrydoy, M., Oldenburg, J., Klepp, O., Bremnes, R. M., Wist, E. A., Wentzel-Larsen, T., Hauge, E. R., Dahl, O., & Fossa, S. D. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp413 · Cited by 162
Self-citationBlood Pressure and Body Mass Index in Long-Term Survivors of Testicular Cancer
Haugnes, H. S., Aass, N., Fosså, S. D., Dahl, O., Klepp, O., Wist, E., Wilsgaard, T., & Bremnes, R. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.882 · Cited by 160
Self-citationNuver, J., Smit, A. J., Sleijfer, D. T., van Gessel, A. I., van Roon, A. M., van der Meer, J., van den Berg, M. P., Burgerhof, J. G. M., Hoekstra, H. J., Sluiter, W. J., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.012 · Cited by 149
Long-term platinum retention after treatment with cisplatin and oxaliplatin
Brouwers, E. E. M., Huitema, A. D. R., Beijnen, J. H., & Schellens, J. H. M. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-7 · Cited by 107
Increase in Weight in All Birth Cohorts in a General Population
Jacobsen, B. K., Njølstad, I., Thune, I., Wilsgaard, T., Løchen, M., & Schirmer, H. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.466 · Cited by 85
Self-citationIncreased mortality rates in young and middle-aged patients with malignant germ cell tumours
Fosså, S. D., Aass, N., Harvei, S., & Tretli, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601558 · Cited by 84
Self-citationOndansetron: a new antiemetic for patients receiving cisplatin chemotherapy.
Einhorn, L. H., Nagy, C. K., Werner, K., & Finn, A. L. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.4.731 · Cited by 80
The level of physical activity in long-term survivors of testicular cancer
Thorsen, L., Nystad, W., Dahl, O., Klepp, O., Bremnes, R. M., Wist, E., & Fosså, S. D. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00151-5 · Cited by 66
Self-citationAbdominal radiotherapy is a cause for chronic pancreatitis
Lévy, P., Menzelxhiu, A., Paillot, B., Fléjou, J. F., Fléjou, J. F., & Bernades, P. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90911-u · Cited by 55
Wethal, T., KJEKSHUS, J. K., Røislien, J., Ueland, T., Andreassen, A. K., Wergeland, R., Aukrust, P., & Fosså, S. D. (2007) · Journal of Cancer Survivorship · doi:10.1007/s11764-007-0012-3 · Cited by 54
Self-citationCisplatin up‐regulates ICAM‐1 expression in endothelial cell via a NF‐κB dependent pathway
Yu, M., Han, J., Cui, P., Dai, M., Li, H., Zhang, J., & Xiu, R. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00696.x · Cited by 51
Haugnes, H. S., Aass, N., Fosså, S. D., Dahl, O., Klepp, O., Wist, E., Wilsgaard, T., & Bremnes, R. M. (2008) · Journal of Cancer Survivorship · doi:10.1007/s11764-008-0054-1 · Cited by 46
Self-citationRothman, K. J., Huybrechts, K. F., & Murray, E. J. (2024) · doi:10.1093/oso/9780197751541.001.0001 · Cited by 12
Cited by
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
A population-based study of cardiovascular disease mortality risk in US cancer patients
Sturgeon, K. M., Deng, L., Bluethmann, S. M., Zhou, S., Trifiletti, D. M., Jiang, C., Kelly, S. P., & Zaorsky, N. G. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz766 · Cited by 923
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac106 · Cited by 507
Metadata
- Authors
- Haugnes, H. S., Wethal, T., Aass, N., Dahl, O., Klepp, O., Langberg, C. W., Wilsgaard, T., Bremnes, R. M., & Fosså, S. D.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-10-20
- Volume
- 28
- Issue
- 30
- Pages
- 4649-4657
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2136361773
- Cited by
- 404
- References
- 34
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.